This statistic shows the turnover of non-reimbursable medicines in metropolitan France from 2010 to 2016, in manufacturing price excluding tax and in million euros. In 2016, the market for non-refundable medicines sold in France represented around two billion euros.
Turnover of non-reimbursable medicines in France from 2010 to 2016, in manufacturer price excluding taxes* (in million euros)
Loading statistic...
Basic Account
Get to know the platform
You only have access to basic statistics.
Starter Account
The ideal entry-level account for individual users
- Instant access to 1m statistics
- Download in XLS, PDF & PNG format
- Detailed references
$199 USD / Month *
Professional Account
Full access
Business Solutions including all features.
* Prices do not include sales tax.
Other statistics that may interest you Statistics on
About the industry
10
- Basic Statistic Global pharmaceutical revenue by technology 2012-2026
- Basic Statistic Total turnover of the French medicines market 2010-2018
- Basic Statistic Distribution of the turnover of the pharmaceuticals market in France 2017, by segment
- Basic Statistic Definition of specialty drugs by PBMs and pharmacy executives 2011
- Basic Statistic Trade balance in high technology sectors of EU countries 2022
- Premium Statistic Pharmaceutical exports value in Jamaica 2014-2021
- Premium Statistic Pharmaceutical exports value in Nicaragua 2014-2022
- Premium Statistic Pharmaceutical exports value in Panama 2013-2021
- Premium Statistic Pharmaceutical exports value in Paraguay 2014-2022
- Premium Statistic Pharmaceutical exports value in El Salvador 2014-2022
About the region
10
- Basic Statistic Companies in the manufacture of pharmaceutical products in France 2009-2020
- Basic Statistic Number of employees of pharmaceutical companies by region France 2020
- Basic Statistic Turnover of medicines sold in retail pharmacies in France 2005-2018
- Basic Statistic Turnover of medicines distributed in hospitals in France 2010-2018
- Basic Statistic Breakdown of the workforce of Sanofi 2018, by geographical location
- Basic Statistic Sanofi's workforce in 2018, by segment
- Basic Statistic Breakdown of employees of drug companies by age France 2014
- Premium Statistic Boiron laboratories turnover in 2022, by region
- Premium Statistic Net profit of Boiron laboratories 2013-2022, per share
- Premium Statistic Net investments of Boiron laboratories 2014-2022
Selected statistics
7
- Premium Statistic Pfizer's ad spending 2008-2023
- Premium Statistic Annual revenue of Sinopharm 2010-2022
- Premium Statistic Number of employees at Sinopharm 2011-2022
- Premium Statistic Annual revenue of Shanghai Pharmaceuticals 2011-2022
- Premium Statistic Revenue of Sinopharm 2011-2022, by category
- Basic Statistic M&A capacities - changes for the global pharma industry 2008-2015
- Premium Statistic Enterprise and brand value of Shoppers Drug Mart in 2012
Other regions
10
- Premium Statistic Pharmaceutical industry: global breakdown in the sale of new drugs 2004-2022
- Basic Statistic Share of biotech firms active in COVID-19 R&D in Italy 2020
- Basic Statistic Leading antianginal drugs dispensed in England 2022, by item number
- Premium Statistic Size of the U.S. vaccine market by age 2014-2024
- Premium Statistic Brazil: Hypera Pharma's ad spending 2016-2018
- Premium Statistic Revenue market share of opioid analgesics sold in Spain by company 2017-2018
- Premium Statistic Parapharmaceuticals sales in Russia 2019-2020, by product
- Premium Statistic Revenue generated by high-tech companies through new products 2021, by industry
- Premium Statistic Share of expenditure on pharmaceuticals in Denmark by type 2021
- Premium Statistic Number of pharmacies in Norway 2009-2023
Related statistics
10
- Premium Statistic Turnover of Boiron laboratories in North America 2022, by country
- Premium Statistic Turnover of the nonproprietary drugs segment of Boiron in 2022, by region
- Premium Statistic Share capital of Boiron laboratories 2012-2022
- Premium Statistic Global turnover of Boiron laboratories 2012-2022
- Premium Statistic Global turnover of Boiron's specialties segment 2022, by region
- Premium Statistic Turnover of Boiron laboratories abroad 2012-2022
- Premium Statistic Boiron's stock price at the end of the year 2012-2022
- Premium Statistic EBITDA of Boiron laboratories 2012-2022
- Premium Statistic Cashflow of Boiron laboratories 2013-2022
- Premium Statistic Boiron laboratories' market capitalization at the end of the year 2012-2022
Further related statistics
10
- Merck & Co - expenditure on research and development 2006-2023
- Merck & Co total assets 2009-2023
- Sanofi's total assets 2007-2023
- Pfizer's revenues in the U.S. and abroad 2009-2023
- AstraZeneca's revenue from top product Pulmicort 2006-2023
- AstraZeneca's expenditure on research and development 2006-2023
- Sales of Johnson & Johnson worldwide 2011-2023, by segment
- Johnson & Johnson's number of employees 2004-2023
- Sales of Johnson & Johnson 2006-2023 by region
- CVS Health's total assets 2005-2023
Further Content: You might find this interesting as well
Statistics
- Merck & Co - expenditure on research and development 2006-2023
- Merck & Co total assets 2009-2023
- Sanofi's total assets 2007-2023
- Pfizer's revenues in the U.S. and abroad 2009-2023
- AstraZeneca's revenue from top product Pulmicort 2006-2023
- AstraZeneca's expenditure on research and development 2006-2023
- Sales of Johnson & Johnson worldwide 2011-2023, by segment
- Johnson & Johnson's number of employees 2004-2023
- Sales of Johnson & Johnson 2006-2023 by region
- CVS Health's total assets 2005-2023
LEEM. (September 1, 2017). Turnover of non-reimbursable medicines in France from 2010 to 2016, in manufacturer price excluding taxes* (in million euros) [Graph]. In Statista. Retrieved March 19, 2024, from https://www.statista.com/statistics/783748/non-reimbursable-drug-sales-france/
LEEM. "Turnover of non-reimbursable medicines in France from 2010 to 2016, in manufacturer price excluding taxes* (in million euros)." Chart. September 1, 2017. Statista. Accessed March 19, 2024. https://www.statista.com/statistics/783748/non-reimbursable-drug-sales-france/
LEEM. (2017). Turnover of non-reimbursable medicines in France from 2010 to 2016, in manufacturer price excluding taxes* (in million euros). Statista. Statista Inc.. Accessed: March 19, 2024. https://www.statista.com/statistics/783748/non-reimbursable-drug-sales-france/
LEEM. "Turnover of Non-reimbursable Medicines in France from 2010 to 2016, in Manufacturer Price excluding Taxes* (in Million Euros)." Statista, Statista Inc., 1 Sep 2017, https://www.statista.com/statistics/783748/non-reimbursable-drug-sales-france/
LEEM, Turnover of non-reimbursable medicines in France from 2010 to 2016, in manufacturer price excluding taxes* (in million euros) Statista, https://www.statista.com/statistics/783748/non-reimbursable-drug-sales-france/ (last visited March 19, 2024)
Turnover of non-reimbursable medicines in France from 2010 to 2016, in manufacturer price excluding taxes* (in million euros) [Graph], LEEM, September 1, 2017. [Online]. Available: https://www.statista.com/statistics/783748/non-reimbursable-drug-sales-france/